Evidence map›Paper›PMID 29062922›Full record

ArticleSynthetic and systems biotechnology2016

Interrogation of

Jinsong Chen, Mei Liu, Xueting Liu, Jin Miao, Chengzhang Fu, Heyong Gao, Rolf Müller, Qing Zhang, Lixin Zhang

Open access · goldAbstract read
In one paragraph

Article in Synthetic and systems biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Potential ofMetabolites · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Jinsong ChenChinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Mei LiuChinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Xueting LiuChinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Jin MiaoChinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Chengzhang FuChinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Heyong GaoInner Mongolia New Veyong Biochemical Co., Ltd, Inner Mongolia Dalad Banner, China.
Rolf MüllerHelmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research, 66123, Saarbrücken, Germany.
Qing ZhangInner Mongolia New Veyong Biochemical Co., Ltd, Inner Mongolia Dalad Banner, China.
Lixin ZhangChinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Institute of Microbiology · CNChinese Academy of Sciences · CNHelmholtz Centre for Infection Research · DEHelmholtz Institute for Pharmaceutical Research Saarland · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2015 Nobel Prize in Physiology or Medicine has been awarded to avermectins and artemisinin, respectively. Avermectins produced by

Indexed as

APGD, atmospheric pressure glow dischargeAvermectinsBCDH, branched-chain alpha-keto acid dehydrogenaseChIP, chromatin immunoprecipitationDO, dissolved oxygenEER, ethanol evolution rateGBL, gamma-butyrolactoneHMGE, high-magnet gravitational environmentIB-CoA, isobutyryl-CoAMB-CoA, 2-methybutyryl-CoAMDR-TB, multidrug-resistant tuberculosisMetabolic engineeringMM-CoA, methylmalonyl- CoAMMS, methyl methanesulphonateMRSA, methicillin-resistant Staphylococcus aureusMTP, microtiter platesNA, nitrous acidNTG, N-methyl-N-nitro-N-nitrosoguanidineOUR, oxygen uptake ratePBD, Plackett–Burman designRF, radio frequencyRRF, ribosome recycling factorSAM, S-adenosylmethionineSTPK, serine-threonine protein kinasesStreptomyces avermitilisSynthetic biologyTAR, transformation-assisted recombinationUV, ultraviolet raysXDR-TB, extensively drug-resistant tuberculosis

Identifiers

PMID29062922
PMCPMC5640586
OpenAlexW2337517412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.